MENU

About us

NuChem Therapeutics Inc. is a privately held CRO that specializes in medicinal chemistry and the custom synthesis of small molecules and peptides. The company was launched in 2011 with financial backing from AmorChem L.P.. Since then we have established a diverse customer base of biotech, pharma and academic research laboratories within North America.

Our scientific team consists of experienced researchers recruited from former pharmaceutical companies in Montreal including AstraZeneca and Merck. We have also drawn from the strong academic pool of young scientists produced by Canadian universities to create a dynamic mix of youth and experience.

Our senior team members have extensive experience in drug discovery project management.  This expertise was developed while working in a broad range of therapeutic areas including inflammation, diabetes, bone, obesity, infectious diseases, cancer and pain.  Many of our senior scientists played key roles in the identification of numerous preclinical candidates and made critical contributions to the research efforts that led to several approved and marketed drugs including Singulair®, Arcoxia® and Tredaptive®.

Medicinal Chemistry is our passion.